BEAM

BEAM THERAPEUTICS INC

BEAM·07373V105·US·Common Stock·Healthcare - Biotechnology-13D/G

BEAM (BEAM THERAPEUTICS INC) is held by 141 institutional investors as of Q2 2026. Largest holders: FMR LLC ($432.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. ($351.3M), ARK Investment Management LLC ($351.3M). Net institutional sentiment: Mixed.

141
Holders
(8 Elite)
$3.1B
Total Value
63% (136)
Consensus
86 buying - 50 selling
13F: Insider & Congress: Updated regularly
BEAM

Smart Money Verdict

View all
Loading verdict
Held by 141 funds
8 elite

Who's Trading

Source dates: Price Aug 31, 2026 · Insiders Jul 29, 2026 · Activists Aug 14, 2026 · Congress none

ActivistARK Investment Management LLCARK Investment Management LLC9.9%Aug 14, 2026
ActivistFarallon Capital Management, L.L.C.Farallon Capital Management, L.L.C.10.0%Aug 13, 2026
InsiderSASimon AmySell $429KJul 27, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
12.6M(+1.3%)$432.7M0.0%+36.71%
32
Increased
10.2M(+1.0%)$351.3M1.6%-25.71%
49
Decreased
10.2M(-15.7%)$351.3M2.3%-41.57%
0
Increased
9M(+6.0%)$308.8M0.0%+14.04%
33
Increased
5.8M(+2.2%)$200M0.0%+10.65%
31
Increased
4.9M(+7.7%)$168.9M0.0%+5.75%
33
Increased
4.6M(+5.1%)$157.9M0.0%+6.38%
32
Decreased
3.5M(-9.7%)$118.6M0.1%-0.20%
0
Decreased
3.5M(-9.7%)$118.5M1.5%-0.18%
0
Increased
2.6M(+7.4%)$89.1M0.0%-21.95%
32
Increased
2.2M(+3.3%)$76.4M0.0%+12.90%
31
Increased
2M(+200.9%)$67M0.0%-3.04%
48
Decreased
1.6M(-6.2%)$53.3M0.0%+9.42%
0
Increased
1.4M(+14.7%)$47.6M0.0%+8.59%
33
Increased
1.3M(+30.3%)$45M0.0%+10.54%
37
Increased
1.1M(+52.4%)$36.6M0.0%-1.26%
41
Increased
933,481(+13.1%)$32M0.0%-17.29%
33
Increased
885,902(+9.6%)$30.4M0.0%-27.90%
32
Increased
720,648(+33.9%)$24.7M0.0%+14.23%
37
Increased
710,712(+3.8%)$24.4M0.0%+6.70%
30

Showing 1-20 of 146

1 / 8
BEAMBEAMBEAM THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used